Sumitomo Mitsui Trust Group
HZNP

Sumitomo Mitsui Trust Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-543,189
Closed -$62.8M – 1164
2023
Q3 		$62.8M Sell
543,189
-8,817
-2% -$947K 0.05% 374
2023
Q2 		$56.8M Sell
552,006
-79,862
-13% -$8.43M 0.04% 432
2023
Q1 		$69M Sell
631,868
-19,621
-3% -$2.17M 0.05% 395
2022
Q4 		$74.1M Buy
651,489
+2,262
+0.3% +$188K 0.06% 377
2022
Q3 		$40.2M Buy
649,227
+2,838
+0.4% +$198K 0.03% 543
2022
Q2 		$51.6M Buy
646,389
+31,038
+5% +$2.94M 0.04% 499
2022
Q1 		$64.7M Buy
+615,351
New +$60M 0.04% 453

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return